Processa Pharmaceuticals, Inc. Proceeds from Collection of (Payments to Fund) Long-term Loans to Related Parties
Processa Pharmaceuticals, Inc. (PCSA) reported Proceeds from Collection of (Payments to Fund) Long-term Loans to Related Parties of $73.36 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2015-04-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromPaymentsForLongTermLoansForRelatedParties · last filed 2015-04-14
- Processa Pharmaceuticals, Inc. proceeds from collection of (payments to fund) long-term loans to related parties for fiscal 2013 was $73.36K.
| Period end | Proceeds from Collection of (Payments to Fund) Long-term Loans to Related Parties 12 month |
|---|---|
| 2013-12-31 | $73.36K 10-K · filed 2015-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |